Neuro-Ophthalmological Manifestations of Horner’s Syndrome: Current Perspectives
Rym Maamouri, Molka Ferchichi, Yasmine Houmane, Zaineb Gharbi, Monia Cheour Department of Ophthalmology, Habib Thameur Hospital, Tunis, TunisiaCorrespondence: Rym Maamouri, Department of Ophthalmology, Habib Thameur Hospital, 3, Rue Ali Ben Ayed, Montfleury, Tunis, 1089, Tunisia, Tel +21698314970, E...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-07-01
|
| Series: | Eye and Brain |
| Subjects: | |
| Online Access: | https://www.dovepress.com/neuro-ophthalmological-manifestations-of-horners-syndrome-current-pers-peer-reviewed-fulltext-article-EB |
| _version_ | 1827899446433677312 |
|---|---|
| author | Maamouri R Ferchichi M Houmane Y Gharbi Z Cheour M |
| author_facet | Maamouri R Ferchichi M Houmane Y Gharbi Z Cheour M |
| author_sort | Maamouri R |
| collection | DOAJ |
| description | Rym Maamouri, Molka Ferchichi, Yasmine Houmane, Zaineb Gharbi, Monia Cheour Department of Ophthalmology, Habib Thameur Hospital, Tunis, TunisiaCorrespondence: Rym Maamouri, Department of Ophthalmology, Habib Thameur Hospital, 3, Rue Ali Ben Ayed, Montfleury, Tunis, 1089, Tunisia, Tel +21698314970, Email ryma.maamouri@fmt.utm.tnAbstract: Horner’s syndrome (HS) is caused by a damage to the oculosympathetic pathway. HS may be congenital, but it is usually acquired and may reveal a life-threatening condition. According to the anatomic location of the underlying pathologic process, HS is classified as central, pre- or postganglionic, when the lesion affects the first, second or third-order neuron, respectively. Pharmacological testing, if available, can be used to differentiate HS from « pseudo-HS » in patients with mild symptoms. Given the financial burden that imaging of the entire oculosympathetic pathway represents, a targeted imaging approach is advised. Although in the majority of cases, clinical examination may predict etiology, in other cases pharmacological testing can help in the localization process. We searched PubMed data base for papers published before December 2022 that concerned Horner’s syndrome, its neuro-ophthalmological manifestations and diagnosis. In this article, we describe the main neuro-ophthalmological manifestations of the three types of HS, the most common etiologies, and a targeted diagnostic strategy in each type.Keywords: Horner’s syndrome, neuro-ophthalmology, pharmacological testing |
| first_indexed | 2024-03-12T23:18:07Z |
| format | Article |
| id | doaj.art-27a99607fc834656a65128cf96a34532 |
| institution | Directory Open Access Journal |
| issn | 1179-2744 |
| language | English |
| last_indexed | 2024-03-12T23:18:07Z |
| publishDate | 2023-07-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Eye and Brain |
| spelling | doaj.art-27a99607fc834656a65128cf96a345322023-07-16T16:02:53ZengDove Medical PressEye and Brain1179-27442023-07-01Volume 159110085130Neuro-Ophthalmological Manifestations of Horner’s Syndrome: Current PerspectivesMaamouri RFerchichi MHoumane YGharbi ZCheour MRym Maamouri, Molka Ferchichi, Yasmine Houmane, Zaineb Gharbi, Monia Cheour Department of Ophthalmology, Habib Thameur Hospital, Tunis, TunisiaCorrespondence: Rym Maamouri, Department of Ophthalmology, Habib Thameur Hospital, 3, Rue Ali Ben Ayed, Montfleury, Tunis, 1089, Tunisia, Tel +21698314970, Email ryma.maamouri@fmt.utm.tnAbstract: Horner’s syndrome (HS) is caused by a damage to the oculosympathetic pathway. HS may be congenital, but it is usually acquired and may reveal a life-threatening condition. According to the anatomic location of the underlying pathologic process, HS is classified as central, pre- or postganglionic, when the lesion affects the first, second or third-order neuron, respectively. Pharmacological testing, if available, can be used to differentiate HS from « pseudo-HS » in patients with mild symptoms. Given the financial burden that imaging of the entire oculosympathetic pathway represents, a targeted imaging approach is advised. Although in the majority of cases, clinical examination may predict etiology, in other cases pharmacological testing can help in the localization process. We searched PubMed data base for papers published before December 2022 that concerned Horner’s syndrome, its neuro-ophthalmological manifestations and diagnosis. In this article, we describe the main neuro-ophthalmological manifestations of the three types of HS, the most common etiologies, and a targeted diagnostic strategy in each type.Keywords: Horner’s syndrome, neuro-ophthalmology, pharmacological testinghttps://www.dovepress.com/neuro-ophthalmological-manifestations-of-horners-syndrome-current-pers-peer-reviewed-fulltext-article-EBhorner's syndromeneuro-ophthalmologypharmacological testing |
| spellingShingle | Maamouri R Ferchichi M Houmane Y Gharbi Z Cheour M Neuro-Ophthalmological Manifestations of Horner’s Syndrome: Current Perspectives Eye and Brain horner's syndrome neuro-ophthalmology pharmacological testing |
| title | Neuro-Ophthalmological Manifestations of Horner’s Syndrome: Current Perspectives |
| title_full | Neuro-Ophthalmological Manifestations of Horner’s Syndrome: Current Perspectives |
| title_fullStr | Neuro-Ophthalmological Manifestations of Horner’s Syndrome: Current Perspectives |
| title_full_unstemmed | Neuro-Ophthalmological Manifestations of Horner’s Syndrome: Current Perspectives |
| title_short | Neuro-Ophthalmological Manifestations of Horner’s Syndrome: Current Perspectives |
| title_sort | neuro ophthalmological manifestations of horner rsquo s syndrome current perspectives |
| topic | horner's syndrome neuro-ophthalmology pharmacological testing |
| url | https://www.dovepress.com/neuro-ophthalmological-manifestations-of-horners-syndrome-current-pers-peer-reviewed-fulltext-article-EB |
| work_keys_str_mv | AT maamourir neuroophthalmologicalmanifestationsofhornerrsquossyndromecurrentperspectives AT ferchichim neuroophthalmologicalmanifestationsofhornerrsquossyndromecurrentperspectives AT houmaney neuroophthalmologicalmanifestationsofhornerrsquossyndromecurrentperspectives AT gharbiz neuroophthalmologicalmanifestationsofhornerrsquossyndromecurrentperspectives AT cheourm neuroophthalmologicalmanifestationsofhornerrsquossyndromecurrentperspectives |